Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
OZEMPIC FixDose 1 mg Fertpen
Drug
Ozempic, Injektionslösung
Diabetes mellitus Typ 2, Verzögerung des Fortschreitens einer chronischen Nierenerkrankung, Prävention kardiovaskulärer Ereignisse, Verbesserung der Claudicatio intermittens
07.06. – pancreas
HAM – Human medicine
INLFP – Solution for injection in pre-filled pen
BT – Biotechnological
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
7/2/2018
12/31/9999
Dosage strength
Ozempic FixDose 1 mg, Fertigpen (1.34 mg/ml)
Diabetes mellitus Typ 2, Verzögerung des Fortschreitens einer chronischen Nierenerkrankung, Prävention kardiovaskulärer Ereignisse, Verbesserung der Claudicatio intermittens
02
Z – approved
Package
7680666040034
In trade from / since 7/2/2018
A/R – Authorised / referenced
1 x 3 ml
003
Z – approved
Declaration
Component
1.34 mg semaglutidum
dinatrii phosphas dihydricus
propylenglycolum
phenolum
acidum hydrochloridum
natrii hydroxidum
aqua ad iniectabile
0.367 mg natrium
propylenglycolum
phenolum
acidum hydrochloridum
natrii hydroxidum
aqua ad iniectabile
0.367 mg natrium
Spezialitätenliste***
SL
-
-
106.20
None
Yes
10%
No
Authorisation holder
7601001001190
Novo Nordisk Pharma AG
8302 Kloten (ZH)
8302 Kloten (ZH)
Date of the last update to the medicines data
11/1/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.